Zimmer Biomet shares dipped slightly today on fourth-quarter results that came in just ahead of the consensus forecast on Wall Street. Shares of ZBH fell 1.6% to $106.50 apiece in pre-market trading today. The Warsaw, Indiana-based orthopedic device company reported profits of $239.4 million. That equals $1.20 per share on sales of $2.023 billion for […]
Zimmer Biomet
Zimmer Biomet to buy Paragon 28 for $1.2B
Zimmer Biomet is making a significant play in the foot and ankle treatment space, announcing it will spend $1.2 billion to acquire Paragon 28 (NYSE: FNA). Established in 2010, Paragon 28 has a wide suite of surgical offerings and product systems spanning all major foot and ankle segments, including fracture and trauma, deformity correction and […]
Zimmer Biomet wins FDA nod for stemless shoulder system
Zimmer Biomet announced today that it received FDA 510(k) clearance for its OsseoFit stemless shoulder system for total shoulder replacement. Warsaw, Indiana–based Zimmer Biomet designed the implant to match the natural humeral anatomy. It optimizes anatomical fit while maximizing the preservation of healthy bone. The OsseoFit stemless shoulder system expands the company’s total shoulder portfolio […]
Medtech M&A could be on the rise in 2025
Analysts from Bank of America predict a favorable environment for mergers and acquisitions in the medtech space in 2025. Travis Steed, Stephanie Piazzola, Craig Bijou and Enjia Cao say 2024 was “a typical year” in terms of M&A in medtech. They tracked 19 acquisitions of note with around $25 billion in disclosed deal price. Some […]
Layoffs in medtech: These companies recently reduced their workforce
Medtech layoffs are picking up as 2024 draws to a close. Sean Whooley, Associate Editor, and Chris Newmarker, Editor-in-Chief The medical device industry is closing out the year with a fresh round of layoffs. At this point, MassDevice has reported on more than 22,000 medtech job cuts across the industry since mid-2022. (Have a tip […]
Zimmer Biomet wins FDA nod for new total knee component
Zimmer Biomet (NYSE:ZBH) announced today that it received FDA 510(k) clearance for its Persona SoluTion porous plasma spray femur. The total knee implant component offers an alternative for patients with sensitivities to bone cement and/or metal. It features a porous coating for cementless fixation and leverages a proprietary surface treatment designed to enhance wear performance. […]
Zimmer Biomet wins FDA nod for cementless partial knee
Zimmer Biomet (NYSE:ZBH) announced today that it received supplemental FDA premarket approval (PMA) for its Oxford cementless partial knee. Oxford allows surgeons to perform partial knee replacement (PKR) with improved fixation, better long-term implant survival and improved efficiency compared to the Oxford cemented partial knee procedure. Approval came on the back of safety and effectiveness […]
Zimmer Biomet wins CE mark for Persona Knee
Zimmer Biomet (NYSE:ZBH) announced today that it received CE mark approval in Europe for its Persona Revision Knee system. Warsaw, Indiana-based Zimmer Biomet said the addition to its Persona portfolio builds on its commitment to personalized solutions. Persona Revision Knee provides advanced tools for revision knee arthroplasty. The system offers a personalized fit and optimized […]
Zimmer Biomet names Arnold Schwarzenegger chief movement officer
Zimmer Biomet (NYSE:ZBH) announced today that it partnered with Arnold Schwarzenegger as its new chief movement officer. Schwarzenegger, an actor and former governor of California, takes on the strategic role to collaborate closely with Zimmer Biomet to motivate, engage and support individuals to increase mobility, maintain joint health and proactively incorporate movement into their daily […]
NeuroOne expands distro deal with Zimmer Biomet to commercialize neuroablation tech
NeuroOne (Nasdaq:NMTC) announced today that it executed an amendment to its existing distribution agreement with Zimmer Biomet (NYSE:ZBH). The amendment provides Zimmer Biomet with exclusive rights to distribute NeuroOne’s OneRF ablation system for use in the brain. It provides NeuroOne with an upfront payment of $3 million and the potential to earn another milestone payment […]
Zimmer Biomet posts Q3 beat but narrows full-year guidance
Zimmer Biomet (NYSE:ZBH) stock is up a bit on third-quarter results that came in just ahead of the consensus forecast. Shares of ZBH rose more than 1% to $103.88 apiece in pre-market trading today. The Warsaw, Indiana-based orthopedic giant reported profits of $249.1 million. That equals $1.23 per share on sales of $1.82 billion for […]